Saturday, December 15, 2018
Feraccru

Norgine launches Shield’s iron deficiency drug Feraccru in UK

Norgine has launched Feraccru, iron deficiency treatment from Shield Therapeutics, in the UK. Shield has licensed the drug to Norgine for sale in most European...

Managing child’s fever a worry for nearly two thirds of parents, survey finds

Although fever is very common in young children, the majority of parents found to be concerned on their ability to manage their child’s fever...

Brexit: Pharmacists to get emergency powers to ration drugs

Government is set to invoke a ‘serious shortage protocol’, giving pharmacists emergency powers to alter prescriptions without consulting GPs, in the event of a...

Review launched into over-prescribing in the NHS

Health Secretary Matt Hancock has ordered a review into over-prescribing in the NHS, which will be led by Chief Pharmaceutical Officer Dr Keith Ridge. The...
brexit

Additional actions needed to supplement medicine stockpiling: Hancock

Health Secretary Matt Hancock said in a Brexit update to health and care providers that additional actions may be needed to supplement the medicine...

GPhC to adopt new approach in regulating pharmacies

The General Pharmaceutical Council (GPhC), in its meeting yesterday (6 December) agreed on the principles that will guide the regulator’s approach in future. GPhC said...

HEE commits £50 million of workforce development money in advance

Health Education England (HEE) has committed £50m of its 2019-20 workforce development budget in advance to NHS employers to enable them to put in place...

Hancock announces £1 billion extra funding to upgrade NHS services

Health Secretary Matt Hancock today (7 December) announced £963 million of extra funding for health facilities across England. A total of 75 projects will receive...
Tamara Rogers, senior vice president and region head of EMEA for GSK Consumer Healthcare

100 diversity champions help in shaping GSK’s diversity agenda

GSK has created 100 diversity champions who are helping activate GSK’s diversity agenda in the  Europe, Middle East and Africa (EMEA) region. The drug...
Takeda's £46 billion Shire acquisition gets shareholder approval

Takeda’s £46 billion Shire acquisition gets shareholder approval

Japanese drug giant Takeda's mammoth $60 billion takeover of Irish pharmaceuticals firm Shire has been approved by both sets of shareholders, the pair said Wednesday. The proposed...